PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Digestive Diseases that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
Eileen M. O'Reilly, MD, FASCO - Hope Is on the Horizon: Anticipating Novel Treatment Approaches in Advanced Pancreatic Cancer
For the complete activity, including supporting material, please visit https://www.peervoice.com/RAZ860. Presented by Eileen M. O'Reilly, MD, FASCO. Learning Objectives: Recognise patient-reported burdens associated with the diagnosis of advanced pancreatic cancer and how these impact decisions surrounding treatment; Identify therapeutic agents under investigation for the management of advanced pancreatic cancer and their current state of development; Implement current, evidence-based best practices in the management of advanced pancreatic cancer, including providing appropriate mental health support to patients.
4 Sept 2026
Eric Van Cutsem, MD, PhD - Biology that Transcends Tumour Type: Integrating Tumour-Agnostic With Tumour-Specific Treatments for HER2-Positive Gastrointestinal Cancers
For the complete activity, including supporting material, please visit https://www.peervoice.com/VPQ860. Presented by Eric Van Cutsem, MD, PhD; Florian Lordick, MD, PhD; and Lorenza Rimassa, MD. Learning Objectives: Critically evaluate evolving clinical data on biomarker-targeted therapies for advanced gastroesophageal adenocarcinoma (GEA), with particular focus on HER2-positive and other actionable disease subtypes; Appreciate the biologic drivers underlying actionable targets (eg, HER2) and; how drug design and structural innovations translate into antitumour activity; Identify opportunities for evaluating timely use of HER2-directed therapy for advanced HER2-positive gastrointestinal (GI) cancers in later lines.
27 Aug 2026
Hannele Yki-Järvinen, MD, FRCP - Recognising and Referring Individuals With MASH: Practical Pathways for Our Endocrinology Practices
For the complete activity, including supporting material, please visit https://www.peervoice.com/CTG860. Presented by Hannele Yki-Järvinen, MD, FRCP and Jeremy Tomlinson, MD, PhD, FRCP. Learning Objectives: Identify individuals who warrant evaluation for metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis based on the presence of cardiometabolic risk factors; Apply available non-invasive scoring systems such as the Fibrosis-4 (FIB-4) Index to predict presence of hepatic fibrosis; Use the outcomes of non-invasive tests to guide referral of individuals to specialist care for suspected MASH with fibrosis for additional workup and consideration for liver-directed therapy.
Who has been a guest on PeerVoice Digestive Diseases Audio
Names identified in recent episode analyses. Showing up to five guests.
Marla C Dubinsky MD
David T Rubin MD
Albrecht Stenzinger, MD
Podcast Authority Score: 22 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
24
Social presence
0
YouTube
0
Engagement
50
Contact PeerVoice Digestive Diseases Audio
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of PeerVoice Digestive Diseases Audio?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
